Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma

Background: Exploration of serum biomarkers for early detection of upper gastrointestinal cancer is required. Here, we aimed to evaluate the diagnostic potential of serum desmoglein-2 (DSG2) in patients with esophageal squamous cell carcinoma (ESCC) and esophagogastric junction adenocarcinoma (EJA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yin-Qiao, Chu, Ling-Yu, Yang, Tian, Zhang, Biao, Zheng, Zheng-Tan, Xie, Jian-Jun, Xu, Yi-Wei, Fang, Wang-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093696/
https://www.ncbi.nlm.nih.gov/pubmed/35521959
http://dx.doi.org/10.1042/BSR20212612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093696/
https://www.ncbi.nlm.nih.gov/pubmed/35521959
http://dx.doi.org/10.1042/BSR20212612

Ejemplares similares